SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000902664-23-002154
Filing Date
2023-03-08
Accepted
2023-03-08 10:49:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMBRX BIOPHARMA INC. p23-1083sc13d.htm SC 13D 92525
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) p23-1083exh99.htm EX-99.1 3833
  Complete submission text file 0000902664-23-002154.txt   97875
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 729-3339
Ambrx Biopharma Inc. (Subject) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92634 | Film No.: 23715136
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address WHITLEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR
Business Address WHITLEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR (212) 729-7524
Darwin Global Management, Ltd. (Filed by) CIK: 0001839209 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13D